Lannett Co. Inc. Hits New 52-Week High at $19.90 (LCI)
Lannett Co. (NYSE:LCI)’s share price reached a new 52-week high during trading hours on Wednesday, American Banking News reports. The company traded as high as $19.90 and last traded at $19.90, with a volume of 179,058 shares traded. The stock had previously closed at $19.18.
Several analysts have recently commented on the stock. Analysts at Oppenheimer raised their price target on shares of Lannett Co. (NYSE:LCI) to $20.00 in a research note to investors on Wednesday, September 11th. They now have a “hold” rating on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Lannett Co. (NYSE:LCI) in a research note to investors on Tuesday, August 20th. They now have a $16.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Lannett Co. (NYSE:LCI) from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday, July 2nd. They now have a $13.40 price target on the stock.
Lannett Co. has a 52 week low of $3.93 and a 52 week high of $19.86. The stock’s 50-day moving average is $14.74 and its 200-day moving average is $12.42. The company has a market cap of $606.5 million and a price-to-earnings ratio of 41.70.
Lannett Co. (NYSE:LCI) last released its earnings data on Tuesday, September 10th. The company reported $0.12 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.07 by $0.05. The company had revenue of $40.20 million for the quarter, compared to the consensus estimate of $37.89 million. During the same quarter in the prior year, the company posted $0.05 earnings per share. The company’s quarterly revenue was up 12.6% on a year-over-year basis. On average, analysts predict that Lannett Co. will post $0.51 earnings per share for the current fiscal year.
Lannett Company, Inc is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.